Dysregulation of IGF-1 and IL-15 highlights their crucial roles in maintaining muscle protein homeostasis and presents potential therapeutic targets for mitigating muscle atrophy in patients with COPD. This evidence concerns the gene IGF1 and chronic obstructive pulmonary disease.